Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: Pivotal trial data

By Eiermann W.  

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 57-62

Springer Publishing Company

Access to resources Recommend Favorite

Effect of PREDICT on chemotherapy/trastuzumab recommendations in HER2positive patients with earlystage breast cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2757-2761

Spandidos Publications

Access to resources Recommend Favorite

A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patients

By Iwata Hiroji   Narabayashi Masaru   Ito Yoshinori   Saji Shigehira   Fujiwara Yasuhiro   Usami Shigeyuki   Katsura Koichi   Sasaki Yasutsuna  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 621-628

Springer Publishing Company

Access to resources Recommend Favorite

Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients

By Bighin Claudia   Pronzato Paolo   Del Mastro Lucia  

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 955-957

Future Medicine

Access to resources Recommend Favorite

Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

By Bartolotti Marco   Franceschi Enrico   Brandes Alba A  

Future Oncology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1653-1664

Future Medicine

Access to resources Recommend Favorite